Comparison of intermittent audit vs daily documentation of pharmacist interventions.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 222, doi. 10.1093/ajhp/zxaa382
- By:
- Publication type:
- Article
Works matching IS 10792082 AND DT 2021 AND VI 78 AND IP 3
Results: 15
1
2
Association between opioid dose escalation and time to death in a comfort measures only population.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 203, doi. 10.1093/ajhp/zxaa367
- By:
- Publication type:
- Article
3
Postinterview etiquette: Tips for writing thank-you letters.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 184, doi. 10.1093/ajhp/zxaa341
- By:
- Publication type:
- Article
4
Appointment.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 183, doi. 10.1093/ajhp/zxaa439
- Publication type:
- Article
5
In emergencies, Howard University student pharmacists answer the call.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 181, doi. 10.1093/ajhp/zxaa438
- By:
- Publication type:
- Article
6
Pandemic shapes pharmacy residents' experiences.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 182, doi. 10.1093/ajhp/zxaa437
- By:
- Publication type:
- Article
7
A survey of US hospitals' criteria for the allocation of remdesivir to treat COVID-19.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 235, doi. 10.1093/ajhp/zxaa391
- By:
- Publication type:
- Article
8
Nifurtimox.
- Published in:
- 2021
- Publication type:
- Product Review
9
ASHP Guidelines on Emergency Medicine Pharmacist Services.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 261, doi. 10.1093/ajhp/zxaa378
- By:
- Publication type:
- Article
10
Comparison of neonatal outcomes with use of a soybean oil–based injectable lipid emulsion vs a 4-oil emulsion product.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 210, doi. 10.1093/ajhp/zxaa377
- By:
- Publication type:
- Article
11
Biosimilar formulary placement in Medicare Part D prescription drug plans: A case study of infliximab.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 216, doi. 10.1093/ajhp/zxaa376
- By:
- Publication type:
- Article
12
Remote introductory pharmacy practice experiences focused on veterans prescribed chronic opioid therapy.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 242, doi. 10.1093/ajhp/zxaa375
- By:
- Publication type:
- Article
13
Effectiveness and impact of a structured research approach for health-system pharmacy administration and leadership residents.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 229, doi. 10.1093/ajhp/zxaa374
- By:
- Publication type:
- Article
14
Navigating uncharted waters: Developing a standardized approach for evaluating and implementing biosimilar products at a comprehensive cancer center.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 249, doi. 10.1093/ajhp/zxaa373
- By:
- Publication type:
- Article
15
Systemic targeted and immunotherapy for advanced hepatocellular carcinoma.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 3, p. 187, doi. 10.1093/ajhp/zxaa365
- By:
- Publication type:
- Article